Walleye Capital’s Zenas BioPharma ZBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.22M Sell
119,551
-89,499
-43% -$2.76M ﹤0.01% 2347
2026
Q2
$5.31M Buy
209,050
+83,818
+67% +$1.67M 0.02% 787
2026
Q1
$2.45M Buy
+125,232
New +$2.81M 0.01% 1307

Other funds holding ZBIO

Walleye Capital's ZBIO Position: Q3 2026 in Review

Walleye Capital reduced its Zenas BioPharma (ZBIO) stake by 43% in Q3 2026, selling an estimated $2.76M and leaving 119,551 shares worth $3.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2347.

Walleye Capital first reported a position in ZBIO in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.31M in Q2 2026. 105 funds tracked by Wall St. Rank hold ZBIO as of Q3 2026.

  • Walleye Capital held 119,551 shares of Zenas BioPharma worth $3.22M as of Q3 2026.
  • Walleye Capital sold 89,499 Zenas BioPharma shares in Q3 2026, an estimated $2.76M.
  • Zenas BioPharma made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2347 holding.
  • Walleye Capital first reported a position in Zenas BioPharma in Q1 2026 and has held it in 3 quarters since.
  • Walleye Capital's Zenas BioPharma position peaked at $5.31M in Q2 2026.
  • 105 funds tracked by Wall St. Rank held Zenas BioPharma as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.